SynopsisDydrogesterone is a progestin medication, which used for a variety of indications, including threatened or recurrent miscarriage during pregnancy, dysfunctional bleeding, infertility due to luteal insufficiency, dysmenorrhea, endometriosis, secondary amenorrhe.....
SynopsisThe global Home Therapeutic Equipment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Home Therapeutic Equipment in various end use industries. The e.....
SynopsisGlobal Bromfenac Sodium API market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led.....
SynopsisNitinol is a special metal that have the ability to restore their original shape after severe deformation. The nitinol medical devices include nitinol stents, nitinol guidewires, nitinol filters etc. The global Nitinol-based Medical Device market size is.....
SynopsisThe global Deoxygenation System market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimati.....
SynopsisThe global GnRH Agonist market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. GnRH, also known as gonadotropin-releasing hormone, is a peptide hormone secreted by.....
SynopsisThe global High Precision Pen Injector market was valued at US$ 3558 million in 2023 and is anticipated to reach US$ 5309.2 million by 2030, witnessing a CAGR of 5.9% during the forecast period 2024-2030. A high-precision pen injector is a medical device.....
SynopsisAdult T-cell lymphoma/leukemia (ATL) is a rare T-cell lymphoproliferative neoplasm caused by human T-lymphotrophic virus 1. In its more common, aggressive forms, ATL carries one of the poorest prognoses of the non-Hodgkin lymphomas. The disease has clinical su.....
SynopsisThe global Minimally Invasive Hemodynamic Monitoring Devices market was valued at US$ 251.1 million in 2023 and is anticipated to reach US$ 316.3 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030. According to our research, .....
SynopsisThe global Ligustrazine Phosphate Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Ligustrazine Phosphate Injection .....
